# Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

> **NCT00922259** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 25 (actual)

## Conditions studied

- Influenza A

## Interventions

- **BIOLOGICAL:** Influenza A H7N7 vaccine

## Key facts

- **NCT ID:** NCT00922259
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00922259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00922259, "Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00922259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*